Waters Co. (NYSE:WAT) Shares Sold by Mn Services Vermogensbeheer B.V.

Mn Services Vermogensbeheer B.V. lowered its stake in shares of Waters Co. (NYSE:WAT) by 2.6% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 22,633 shares of the medical instruments supplier’s stock after selling 600 shares during the period. Mn Services Vermogensbeheer B.V.’s holdings in Waters were worth $8,145,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in WAT. Itau Unibanco Holding S.A. acquired a new stake in shares of Waters during the 2nd quarter worth about $33,000. Blue Trust Inc. lifted its stake in shares of Waters by 190.2% during the second quarter. Blue Trust Inc. now owns 119 shares of the medical instruments supplier’s stock valued at $35,000 after buying an additional 78 shares during the period. TFC Financial Management Inc. boosted its position in Waters by 19,900.0% during the second quarter. TFC Financial Management Inc. now owns 200 shares of the medical instruments supplier’s stock worth $58,000 after acquiring an additional 199 shares during the last quarter. Federated Hermes Inc. acquired a new stake in Waters during the second quarter worth approximately $59,000. Finally, Fidelis Capital Partners LLC purchased a new stake in Waters in the 1st quarter worth approximately $72,000. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Stock Performance

Shares of NYSE:WAT opened at $387.09 on Wednesday. The company has a market cap of $22.99 billion, a P/E ratio of 36.94, a PEG ratio of 7.50 and a beta of 0.97. Waters Co. has a one year low of $241.95 and a one year high of $391.00. The business’s 50-day simple moving average is $343.05 and its 200 day simple moving average is $326.09. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.55 and a current ratio of 2.02.

Waters (NYSE:WAT) last posted its earnings results on Friday, November 1st. The medical instruments supplier reported $2.93 EPS for the quarter, topping analysts’ consensus estimates of $2.68 by $0.25. Waters had a net margin of 21.43% and a return on equity of 49.93%. The business had revenue of $740.30 million for the quarter, compared to analysts’ expectations of $712.99 million. During the same period in the previous year, the company posted $2.84 earnings per share. The business’s revenue for the quarter was up 4.0% compared to the same quarter last year. On average, sell-side analysts forecast that Waters Co. will post 11.67 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the company. Stifel Nicolaus raised their price objective on Waters from $332.00 to $360.00 and gave the stock a “hold” rating in a report on Monday. Barclays raised their price target on Waters from $330.00 to $360.00 and gave the stock an “underweight” rating in a research note on Monday. Jefferies Financial Group raised shares of Waters from a “hold” rating to a “buy” rating and upped their price objective for the company from $355.00 to $415.00 in a research note on Tuesday, October 8th. Leerink Partnrs raised shares of Waters from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 1st. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on shares of Waters from $310.00 to $325.00 and gave the company a “hold” rating in a report on Monday. One analyst has rated the stock with a sell rating, ten have given a hold rating, three have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $365.85.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.